These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New developments in the field of bronchospasmolytics]. Nolte D Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306 [No Abstract] [Full Text] [Related]
8. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study]. Riedl-Seifert R Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910 [No Abstract] [Full Text] [Related]
9. [Treatment of CARA]. Sluiter HJ; Orie NG; de Vries K Ned Tijdschr Geneeskd; 1982 Oct; 126(42):1921-8. PubMed ID: 7144962 [No Abstract] [Full Text] [Related]
10. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators. Chapman KR; Wanner A Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777 [No Abstract] [Full Text] [Related]
11. [Bronchospasmolytic and anti-inflammatory therapy of obstructive respiratory tract diseases]. Wettengel R Internist (Berl); 1995 Jun; 36(6):575-81. PubMed ID: 7665325 [No Abstract] [Full Text] [Related]
12. [Chronic obstructive lung diseases and principles of their treatment]. Pomerantsev VP; Kopalova SM; Maĭchuk EIu Klin Med (Mosk); 1985 Dec; 63(12):106-12. PubMed ID: 3912604 [No Abstract] [Full Text] [Related]
13. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)]. Chillón F Folia Clin Int (Barc); 1973 Jun; 23(6):464-76. PubMed ID: 4805350 [No Abstract] [Full Text] [Related]
14. [Clinical aspects, diagnosis and treatment of obstructive lung diseases among the population of Afghanistan]. Malen'kiĭ VP; Samadi G Ter Arkh; 1988; 60(8):68-71. PubMed ID: 3227481 [TBL] [Abstract][Full Text] [Related]
15. Toxic effects of drugs used in the ICU. Toxic effects of bronchodilators. Truwit JD Crit Care Clin; 1991 Jul; 7(3):639-57. PubMed ID: 1863885 [TBL] [Abstract][Full Text] [Related]
16. The site of action of beta-2-sympathomimetic bronchodilators in patients with chronic obstructive airway disease. Newhouse MT Respiration; 1983; 44(5):395. PubMed ID: 6622858 [No Abstract] [Full Text] [Related]
17. Review of sympathomimetic bronchodilators. Kaatz BL S D J Med; 1979 Mar; 32(3):9-12. PubMed ID: 375388 [No Abstract] [Full Text] [Related]
18. Therapeutic implications of a precise diagnosis of airflow obstruction. Picado C Eur Respir J; 1990 Oct; 3(9):1091-4. PubMed ID: 1981193 [No Abstract] [Full Text] [Related]
19. [Clinical use of atrovent]. Zamotaev IP; Maksimova LN Klin Med (Mosk); 1984 Apr; 62(4):50-4. PubMed ID: 6234428 [No Abstract] [Full Text] [Related]
20. [Spasmolytics in the combined therapy of bronchial asthma]. Zarudiĭ FS Farmakol Toksikol; 1986; 49(2):102-3. PubMed ID: 2872080 [No Abstract] [Full Text] [Related] [Next] [New Search]